Powder
Ground stem bark, used at practitioner-directed dosing.
Powder
Uncaria tomentosa (Rubiaceae) — a woody Amazonian vine named for its sharp, curved thorns, long regarded as a panacea by the Ashaninka and other Peruvian peoples. Its stem bark carries two distinct oxindole alkaloid chemotypes with markedly different biological effects — a chemotype-dependent complexity that runs through nearly every aspect of the plant's research.
Uncaria tomentosa is a woody climbing vine that can reach 30 meters in length, with a trunk up to 20 cm in diameter and stems up to 20 cm across. It bears large glossy leaves and sharp, curved thorns resembling a cat's claw. Native to the tropical Andean rainforests of Peru, Ecuador, and Colombia; the related species Uncaria guianensis is found in French Guiana.
Cat's claw has long served as a panacea for the Ashaninka and other Peruvian peoples, used to treat serious illnesses including asthma, cancer, diabetes, and arthritis. 1
Traditional healers are able to select plants low in tetracyclic oxindole alkaloids (TOA), believed most likely to strengthen immunity — an early, practical form of the chemotype awareness that modern research has since confirmed matters pharmacologically.
A parallel line of ethnobotanical discovery exists in Ancistrocladus korupensis (Ancistrocladaceae) of Cameroon, whose anti-HIV alkaloids (michellamines A and B) illustrate a similar pattern of Indigenous plant knowledge later validated by pharmacological research. 3
⚠ Chemotype Matters
Cat's claw exists as two distinct alkaloid chemotypes (POA and TOA) with different — and reportedly opposing — biological effects. The tetracyclic (TOA) chemotype is considered too immunosuppressive for some traditional uses; correct chemotype identification is essential to predicting a given preparation's effects.
The two alkaloid chemotypes that define cat's claw's immune, anti-inflammatory, and antitumor research — and why identifying the right one matters.
Pentacyclic (POA) and tetracyclic (TOA) oxindole alkaloids define two different chemotypes of the plant, with rynchophylline, 5-carboxystrictosidine, and isopteropodine among the characterized compounds.
Each chemotype shows specific selectivity toward human malignant cells, making correct chemotype identification important for understanding antitumor potential. 13
Clinical studies conducted in Peru have reported an effect in HIV/AIDS specifically with the POA chemotype, since the TOA chemotype is considered too immunosuppressive for this use.
⚠ Preparation Determines Composition
Clinical results vary by preparation, not just by dose.
Clinical data remains insufficient to draw definitive conclusions about cat's claw's effects, since results depend heavily on the nature of the preparation used, which in turn determines its alkaloid composition. 14
The stem bark (and root bark) is used medicinally, prepared across two documented forms.
Ground stem bark, used at practitioner-directed dosing.
Powder
Standardized or freeze-dried extracts of the stem bark.
Extract
A single documented dosing ceiling applies across forms — dosing above this range should be guided by a qualified practitioner.
Stem bark composition only — no gemmotherapy (bud) or essential-oil fraction is documented for this species.
Attributed to the alkaloids, flavan-3-ol monomers, and polyphenols.
Induces lymphocyte proliferation and stimulates interleukin-1 and interleukin-6, macrophages, and phagocytosis. 6789
Inhibits TNF-alpha, to a lesser extent PGE2, and NF-κB activation. 151617
Anticancer properties documented, with each chemotype showing distinct selectivity for malignant cell lines. 10111213
Stimulates macrophage activity and phagocytosis alongside apoptosis in tumor cells.
Cytotoxic against gastric and colonic adenocarcinoma cell lines. 5
Shows activity against Borrelia burgdorferi, evaluated alongside several other botanicals for Lyme disease potential. 19
Rynchophylline is believed to increase levels of neurotransmitters such as dopamine and serotonin. 18
Cat's claw's primary use spans chronic inflammatory and degenerative disease, with additional research interest in oncology and neurological conditions.
Cat's claw's immune and anti-inflammatory effects converge on cytokine signaling, lymphocyte activation, and NF-κB pathway inhibition.
Stem bark extracts stimulate in vitro production of IL-6 and IL-1 in lipopolysaccharide-stimulated alveolar macrophages. 7
Rynchophylline is believed to increase levels of neurotransmitters such as dopamine and serotonin. 18
Cat's claw shows generally low acute toxicity, but genuine, specific precautions apply — particularly around pregnancy, Parkinson's disease, and kidney health.